Roche

The Week Ahead In Biotech: Clinical Readouts In Focus As Earnings Wind Down
Yahoo/Benzinga
Sun, 11/17/19 - 08:47 pm
AHA
The Medicines Company
Intrexon
Alnylam
Pieris
Roche
Roche buys U.S. drugmaker Promedior for up to $1.4 billion to get lung drug
Reuters
Sat, 11/16/19 - 12:01 am
Roche
Promedior
idiopathic pulmonary fibrosis
M&A
Five drugs, including two Novartis therapies, win EMA endorsement
Endpoints
Fri, 11/15/19 - 12:22 pm
EMA
Europe
Novartis
Mayzent
Isturisa
Roche
Polivy
Jazz Pharma
Sunosi
Rigel Pharma
Tavlesse
Roche's Chugai claims Alexion co-opted its patented tech in building Ultomiris
Fierce Pharma
Wed, 11/13/19 - 11:24 pm
Alexion
Chugai
Roche
Ultomiris
patents
Roche tests 'brain shuttle' in humans in Alzheimer's project
Reuters
Mon, 11/11/19 - 08:00 pm
Roche
Alzheimer's disease
monoclonal antibodies
gantenerumab
Roche steers Gazyva into a new PhIII program after combo shows promise in lupus nephritis study
Endpoints
Mon, 11/11/19 - 11:04 am
Roche
monoclonal antibodies
Gazyva
lupus
kidney disease
clinical trials
Roche sets sights on Novartis, Biogen as SMA trial hits target
Yahoo/Reuters
Mon, 11/11/19 - 10:49 am
Roche
SMA
risdiplam
Biogen
Novartis
clinical trials
Roche joins others in dropping myostatin inhibitor for DMD
Pharmaforum
Fri, 11/8/19 - 10:50 am
Roche
Duchenne Muscular Dystrophy
RG6206
myostatin inhibitors
Roche escapes lawsuit claiming it illegally quashed Biocad's biosimilar hopes
Fierce Pharma
Thu, 11/7/19 - 11:13 pm
Roche
Biocad
Russia
biosimilars
Say hello to Roche's worst-case scenario: Teva's Rituxan biosim set to launch in U.S.
Fierce Pharma
Thu, 11/7/19 - 11:05 am
Roche
Teva Pharmaceutical
Celltrion
Rituxan
biosimilars
MabThera
Truxima
Top execs from AstraZeneca, Roche, Sanofi and GSK tout China investments at import expo
Fierce Pharma
Thu, 11/7/19 - 10:21 am
China
AstraZeneca
Roche
Sanofi
GSK
Roche pays $200M for rights to Dicerna's hepatitis B RNAi drug
Fierce Biotech
Thu, 10/31/19 - 10:29 am
Roche
Dicerna Pharmaceuticals
RNAi
hepatitis B
DCR-HBVS
Bay Area Life Sciences Professionals Weigh In on Their Ideal Employers
BioSpace
Tue, 10/29/19 - 10:23 am
San Francisco
Bay Area
Genentech
Gilead Sciences
Roche
Amgen
Why Roche's Acquisition Of Spark May Be Complete By Year's End
Investors Business Daily
Sat, 10/26/19 - 02:14 pm
Roche
Spark Therapeutics
M&A
Diagnostics specialists win the US device approval race
EP Vantage
Fri, 10/25/19 - 10:35 am
devices
diagnostics
Roche
FDA
Roche's Tecentriq scores a first-in-class double win in new liver cancer patients
Fierce Pharma
Mon, 10/21/19 - 04:36 pm
Roche
liver cancer
Tecentriq
immuno-oncology
Avastin
Nexavar
FDA approves Roche’s Xofluza for patients at high risk of developing flu-related complications
Pharmaceutical Business Review
Fri, 10/18/19 - 07:48 pm
Roche
FDA
Xofluza
vaccines
influenza
A change of the guard for the world’s biggest cancer companies
EP Vantage
Fri, 10/18/19 - 10:16 am
cancer
Bristol-Myers Squibb
Celgene
M&A
Roche
AstraZeneca
With biosimilar threat under control (for now), Roche savors demand for its new drugs
Endpoints
Wed, 10/16/19 - 12:24 pm
Roche
M&A
Spark Therapeutics
China
Staying Ahead of Biosimilar Competition, Roche's Rituxan Shows Superiority in Rare Autoimmune Skin Disease
BioSpace
Mon, 10/14/19 - 11:06 am
Roche
clinical trials
Rituxan/MabThera
MMF
pemphigus vulgaris

Pages